selected publications
-
academic article in scopus
- COVID-19 classification using thermal images. Journal of Biomedical Optics. 27. 2022
- Spatial interaction between breast cancer and environmental pollution in the Monterrey Metropolitan Area. Heliyon. 7. 2021
- Rapid improvement of a critically ill obstetric patient with SARS-CoV-2 infection after administration of convalescent plasma. International Journal of Gynecology and Obstetrics. 152:439-441. 2021
- Value of a breast imaging unit in the detection of breast cancer in Mexico. ecancermedicalscience. 15. 2021
- Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?. Acta Radiologica. 61:1494-1504. 2020
- Immunotyping of tumor¿infiltrating lymphocytes in triple¿negative breast cancer and genetic characterization. Oncology Letters. 20. 2020
- Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage. Women's Health. 16. 2020
- Genetic alterations of triple negative breast cancer (TNBC) in women from northeastern Mexico. Oncology Letters. 17:3581-3588. 2019
- Resources for the attention of patients with breast cancer in Mexico. Gaceta Mexicana de Oncologia. 18:27-32. 2019
- A solitary presentation of panniculitis in a patient with a history of breast cancer. Annals of Medicine and Surgery. 36:54-57. 2018
- Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer. PLoS ONE. 13. 2018
- Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer. Academic Radiology. 25:179-187. 2018
- Joven & fuerte": Program for young Women with Breast Cancer in Mexico - Initial Results. Revista de Investigacion Clinica. 69:223-228. 2017
- A new gene expression signature for Triple-Negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy. Molecular Medicine. 23:101-111. 2017
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. Lancet, The. 388:2997-3005. 2016
- Efficient gene selection for cancer prognostic biomarkers using swarm optimization and survival analysis. Current Bioinformatics. 11:310-323. 2016